Explore

Trendline Trendline
MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Maryland Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M

MacroGenics to Sell GMP Manufacturing Operations to Bora for $122.5M
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million

Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million

Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million
Trendline Trendline
Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for Strategic Focus

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for Strategic Focus

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for Strategic Focus
Trendline Trendline
Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026